(1R)-(6-Methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate

Catalog No. :
ACSXNK647
CAS No. :
549-60-0
Molecular Formula :
C20H25N2O5P
Molecular Weight :
404.40

IUPAC Name:(1R)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate

(1R)-(6-Methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(1R)-(6-Methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate
IUPAC Name(1R)-(6-methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate
MDL No.MFCD00050909
Molecular FormulaC20H25N2O5P
Molecular Weight404.40
SMILESC=C[C@H]1CN2CC[C@H]1C[C@H]2[C@H](OP(=O)(O)O)C1=CC=NC2=CC=C(OC)C=C12
InChI KeyUMSGSCJRHFTEGZ-WZBLMQSHSA-N
SynonymQUININE PHOSPHATE;triquinine bis(phosphate);(1R)-(6-Methoxyquinolin-4-yl)((2S,4S,5R)-5-vinylquinuclidin-2-yl)methyl dihydrogen phosphate
CAS No.549-60-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACSXNK647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHSGN163 route compound structure diagram
    ACHSGN163130-89-2 In Stock
  2. Plus
  3. ACCQCK608 route compound structure diagram
    ACCQCK6081306-06-5
  4. Then
  5. ACSXNK647 route product structure diagram
    ACSXNK647549-60-0
Inquiry

2. ACSXNK647 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSXNK647 route product structure diagram
    ACSXNK647549-60-0
Inquiry

Comments (0)